Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Randomized trial of anetumab ravtansine and pembrolizumab compared to pembrolizumab for mesothelioma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Randomized trial of anetumab ravtansine and pembrolizumab compared to pembrolizumab for mesothelioma.
Randomized trial of anetumab ravtansine and pembrolizumab compared to pembrolizumab for mesothelioma. Lung Cancer. 2024 Sep; 195:107928.
View in:
PubMed
subject areas
Aged
Aged, 80 and over
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Female
GPI-Linked Proteins
Humans
Immunoconjugates
Lung Neoplasms
Male
Maytansine
Mesothelioma
Middle Aged
Pleural Neoplasms
authors with profiles
Hedy Kindler